Hypogonadism may be classified as primary (testicular origin) or secondary (hypothalamic–pituitary origin). Clinical manifestations include reduced libido, erectile dysfunction, decreased muscle mass, mood disturbances, and infertility.
Guidelines from the Endocrine Society emphasize the importance of correlating symptoms with laboratory confirmation before initiating testosterone replacement therapy.
Treatment options include injectable, transdermal, or oral testosterone formulations. Monitoring involves hematocrit levels, lipid profile, and prostate health assessment.
Careful patient selection is essential to optimize erotic therapeutic outcomes.
Leave a Reply